Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones ...
DISTRIBUTION FINALISATION ANNOUNCEMENT PERIOD ENDED 31 DECEMBER 2025 The Manager and Trustees of the Sygnia Itrix Collective Investment Scheme (being Sygnia Itrix (RF) (Pty) Limited and Standard Bank ...
The Wire on MSNOpinion
Dear Southasians, your fear, fatigue and convenience are normalising injustice
It is cruel to present systemic injustice as due procedure, as some Southasian states have been doing, forgetting that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback